Menu

Blog

Archive for the ‘biotech/medical’ category: Page 7

Jun 6, 2020

Rapamycin Fights Gum Disease and Spurs Bone Growth in Older Mice

Posted by in categories: biotech/medical, life extension

Rapamycin, a drug that has life-extending effects on mice (and possibly dogs and humans), also reverses age-related dental problems in mice. 🦷 Out now in eLife from researchers at The University of Washington School of Dentistry & JAX’s Kaczorowski Lab:


Rapamycin, which has life-extending effects on mice, also reverses age-related dental problems such as periodontitis and regrows bones in the animals.

Continue reading “Rapamycin Fights Gum Disease and Spurs Bone Growth in Older Mice” »

Jun 6, 2020

Locus Robotics raises another $40M as retailers increasingly look to automate

Posted by in categories: biotech/medical, business, information science, robotics/AI

The COVID-19 pandemic will have a profound impact on robotics, as more companies look to automation as a way forward. While wide-scale automation had long seemed like an inevitability, the pandemic is set to accelerate the push as corporations look for processes that remove the human element from the equation.

Of course, Locus Robotics hasn’t had too much of an issue raising money previously. The Massachusetts-based startup, which raised $26 million back in April of last year, is adding a $40 million Series D to its funds. That brings the full amount to north of $105 million. This latest round, led by Zebra Technologies, comes as the company looks to expand operations with the launch of a European HQ.

“The new funding allows Locus to accelerate expansion into global markets,” CEO Rick Faulk said in a release, “enabling us to strengthen our support of retail, industrial, healthcare, and 3PL businesses around the world as they navigate through the COVID-19 pandemic, ensuring that they come out stronger on the other side.”

Continue reading “Locus Robotics raises another $40M as retailers increasingly look to automate” »

Jun 6, 2020

Cracking open the proton

Posted by in categories: biotech/medical, supercomputing

:0000


Physicists around the world are cracking open the proton, within the nucleus of the atom, to see what’s inside.

The proton is a fundamental building block of the atomic nucleus, and among other things it’s used as a medical probe in magnetic resonance imaging. It also has a rich inner structure made up of subatomic particles called quarks and gluons, which bind the quarks together.

Continue reading “Cracking open the proton” »

Jun 6, 2020

Scientists find a switch to flip and turn off breast cancer growth and metastasis

Posted by in categories: biotech/medical, futurism

Researchers at Tulane University School of Medicine identified a gene that causes an aggressive form of breast cancer to rapidly grow. More importantly, they have also discovered a way to “turn it off” and inhibit cancer from occurring. The animal study results have been so compelling that the team is now working on FDA approval to begin clinical trials and has published details in the journal Scientific Reports.

The team led by Dr. Reza Izadpanah examined the role two genes, including one whose involvement in cancer was discovered by Tulane researchers, play in causing triple negative breast cancer (TNBC). TNBC is considered to be the most aggressive of breast cancers, with a much poorer prognosis for treatment and survival. Izadpanah’s team specifically identified an inhibitor of the TRAF3IP2 gene, which was proven to suppress the growth and spread (metastasis) of TNBC in mouse models that closely resemble humans.

In parallel studies looking at a duo of genes—TRAF3IP2 and Rab27a, which play roles in the secretion of substances that can cause —the research teams studied what happens when they were stopped from functioning. Suppressing the expression of either gene led to a decline in both and the spread of cancer to other organs. Izadpanah says that when Rab27a was silenced, the tumor did not grow but was still spreading a small number of cancer cells to other parts of the body. However, when the TRAF3IP2 gene was turned off, they found no spread (known as “metastasis” or “micrometastasis”) of the original tumor cells for a full year following the treatment. Even more beneficial, inhibiting the TRAF3IP2 gene not only stopped future tumor growth but caused existing tumors to shrink to undetectable levels.

Jun 6, 2020

Chasing immortality | The Future is Now

Posted by in categories: biotech/medical, education, genetics, life extension, neuroscience

#Eternal life might not be attainable in the near future, but genetic engineers and doctors are working on new life extension technology. The research could lead to keeping our bodies young, and scientists are developing ways of downloading our brain’s consciousness onto digital media once the body is at the end of its life cycle.

#RT #Documentary offers you in-depth documentary films on topics that will leave no one indifferent. It’s not just front-page stories and global events, but issues that extend beyond the headlines. Social and environmental issues, shocking traditions, intriguing personalities, history, sports and so much more – we have documentaries to suit every taste. RTD’s film crews travel far and wide to bring you diverse and compelling stories. Discover the world with us!

Continue reading “Chasing immortality | The Future is Now” »

Jun 6, 2020

Genetically Modifying Humans to Reverse Aging — Today – EP15: Liz Parrish (BioViva)

Posted by in categories: biotech/medical, genetics, life extension

SEE MORE EPISODES like this https://podcast.hyperwellbeing.com/

In this fifteenth episode, Liz Parrish shares her quest for radical life extension and details her two completed gene therapies. She describes the regenerative medical tourism available today for increased lifespan and costs. She relates her company’s mission to create a human that regenerates faster than they degenerate. She details her upcoming gene therapies, including upgraded IQ.

Continue reading “Genetically Modifying Humans to Reverse Aging — Today – EP15: Liz Parrish (BioViva)” »

Jun 6, 2020

Wear masks in public, WHO says in new advice

Posted by in category: biotech/medical

The World Health Organization (WHO) has changed its advice on face masks, saying they should be worn in public where social distancing is not possible to help stop the spread of coronavirus.

The global body said new information showed they could provide “a barrier for potentially infectious droplets”.

Some countries already recommend or mandate face coverings in public.

Continue reading “Wear masks in public, WHO says in new advice” »

Jun 6, 2020

Scientists find link between COVID-19 severity and genetics

Posted by in categories: biotech/medical, genetics

Chinese scientists also found that patients with blood type A were more likely to develop a severe case of COVID-19, according to the Times.

While the Chinese study does support the new study, questions remain on why blood type affects the severity of the illness. “That is haunting me, quite honestly,” said Franke.

The locus where the blood-type gene is located also contains DNA that acts an on-off switch for a gene producing a protein that triggers strong immune responses.

Continue reading “Scientists find link between COVID-19 severity and genetics” »

Jun 6, 2020

Coronavirus vaccine: White House narrows focus, a billionaire scientist jumps in the race

Posted by in category: biotech/medical

Global efforts to develop a coronavirus vaccine continue, even as mass protests against racial injustice and police brutality persist in cities across the United States and around the world, raising concerns that the gatherings could spark new waves of infection.

As the number of confirmed coronavirus cases rose to nearly 6.3 million worldwide, experts reaffirmed their hope that at least one promising vaccine candidate could be identified by the end of the year.

Jun 6, 2020

Lancet, NEJM retract Covid-19 studies that sparked backlash

Posted by in category: biotech/medical

The Lancet, one of the world’s top medical journals, on Thursday retracted an influential study that raised alarms about the safety of the experimental Covid-19 treatments chloroquine and hydroxychloroquine amid scrutiny of the data underlying the paper.

Just over an hour later, the New England Journal of Medicine retracted a separate study, focused on blood pressure medications in Covid-19, that relied on data from the same company.


The journals said the authors of the paper were unable to complete an independent audit of the data underpinning their analyses.

Continue reading “Lancet, NEJM retract Covid-19 studies that sparked backlash” »

Page 7 of 1,173First4567891011Last